Assembly Biosciences, Inc. (ASMB) Capital expenditures 2016–2025
Assembly Biosciences, Inc. (ASMB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$66,000FY2025 · since FY2016: $147,000 → $66,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $66,000 | +135.7% |
| FY2024 | $28,000 | -89.0% |
| FY2023 | $255,000 | +150.0% |
| FY2022 | $102,000 | -96.7% |
| FY2021 | $3.1M | +558.7% |
| FY2020 | $470,000 | -69.8% |
| FY2019 | $1.6M | +357.1% |
| FY2018 | $340,000 | -60.7% |
| FY2017 | $865,000 | +488.4% |
| FY2016 | $147,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice